Looking to sell LeoLabs stock or options?
LeoLabs is a provider of space situational awareness services and low earth orbit mapping intended to facilitate safe and sustainable space operations. The company uses radar technology to study the earth's ionosphere and provides rapid orbit determination, early operational support, and ongoing conjunction awareness. This allows commercial satellite operators, government regulatory bodies, and space agencies to safely deploy their services and enhance visibility.
GP Bullhound, Dylan Taylor, SRI Ventures, Seraphim Space, CSC UpShot Ventures, WERU Investment, AWS Startups, Sparq Capital (United States), MDSV Capital, TriplePoint Capital, 1941, Morgan Brook Capital, John Giampetroni, Horizons Ventures, Marc Bell Capital Partners, Aspire NZ Seed Fund, TriplePoint Venture Growth BDC, Airbus Ventures, Space Capital, Brian Ellerman, Velvet Sea Ventures, Hemisphere Ventures, Dolby Family Ventures, Insight Partners.
LeoLabs is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize LeoLabs stock. Depending on LeoLabs’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange LeoLabs stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of LeoLabs stock in two ways. First, LeoLabs employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your LeoLabs stock. Note that all transactions in LeoLabs shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
LeoLabs stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for LeoLabs stock. Typically, shares of private companies like LeoLabs are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Feb 2024, LeoLabs is reported to have closed an equity financing in which the investors valued the company at $371M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of LeoLabs shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because LeoLabs is not currently publicly traded, it does not have a ticker symbol.
LeoLabs has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though LeoLabs is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on LeoLabs shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.